News Sentiment

TRAW sentiment intelligence

Traws Pharma Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 49 Balanced news tone 53 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.67 Week of 17 Jul 2026
Weighted tone 49/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

83/100 classification confidence.

Company focus 44

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-11.7% over one week, -21.1% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

Traws Pharma (TRAW) Registration filing Summary

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 83/100 classification
One-week reaction -11.7% Price reacting lower
Trend fit Trend inactive -21.1% over four weeks
Fair value -91.7% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 42
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 44
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 18
TradingView 7
Market source 6
GlobeNewswire 4
Quartr 2
Investing.com Nigeria 2
MT Newswires 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Market update 33
Earnings 13
Regulatory and legal 3
Balance sheet 2
Analyst action 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-53 of 53
TradingView Direct company coverage

Traws Pharma, Inc. Actuals & Estimates (NASDAQ:TRAW)

This article provides an overview of Traws Pharma, Inc. (NASDAQ:TRAW) financials and analyst estimates. Key information includes the current stock price, historical performance, analyst price targets, upcoming earnings dates, and financial metrics such as net income and EBITDA. T

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 13:39
Source
TradingView
TradingView Direct company coverage

0T20 Forecast — Price Target — Prediction for 2027

This article provides a detailed forecast and financial overview for Traws Pharma, Inc. (0T20) on the Frankfurt Stock Exchange, based on analyst ratings and historical data. It includes information on price targets, past earnings, revenue, EBITDA, and key dates such as the next e

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 23:39
Source
TradingView